← Browse by Condition
Medical Condition

blasts 10 percent or more of peripheral blood white cells

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT02115295 Phase 2
Recruiting

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

Enrollment
508 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →